INNV — InnovAge Holding Corp.

InnovAge Holding Corp. Q2 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenues: $239.7 million, up 14.7% year-over-year (YoY) from $209 million.
• Adjusted EBITDA: $22.2 million, significantly improved from $5.9 million YoY, with an adjusted EBITDA margin of 9.2%, achieving the target of 8-9% for the first time.
• Net Income: $11.8 million, compared to a net loss of $13.5 million in the prior year.
• Census Growth: Approximately 8,010 participants served, a 7.1% increase YoY, with 23,960 member months, up 7.9% YoY.
• External Provider Costs: Increased to $112 million, up 3.8% YoY, primarily due to higher member months.
• Cash Position: Ended the quarter with $83.2 million in cash and equivalents, plus $42.8 million in short-term investments.

2. Strategic Updates and Business Highlights

• InnovAge emphasized a disciplined approach to operational and clinical initiatives, resulting in improved financial performance.
• Significant progress was made in revenue integrity, particularly concerning Medicaid eligibility and redeterminations, leading to reduced revenue reserves and reinstated coverage for participants.
• The company is focusing on enhancing participant experience through systematic feedback, service recovery, and consistent onboarding processes.
• Ongoing initiatives include optimizing care delivery, reducing practice variation among providers, and leveraging AI for operational efficiencies.
• Governance improvements were noted, with new board members appointed to strengthen oversight.

3. Forward Guidance and Outlook

• Revised Full-Year Guidance:
  • Member months expected between 92,900 and 95,700.
  • Total revenue projected between $925 million and $950 million.
  • Adjusted EBITDA forecasted between $70 million and $75 million.
  • De novo losses anticipated in the range of $11.5 to $13.5 million.
• The company expressed confidence in its ability to sustain improved performance through ongoing operational enhancements and favorable Medicaid rates.

4. Bad News, Challenges, or Points of Concern

• Enrollment Variability: The third quarter is typically softer due to seasonal factors, including flu season and open enrollment impacts, which could pressure margins.
• Disenrollment Rates: Voluntary disenrollment remains a concern, with approximately 6% annualized, particularly in the first six months of participant engagement.
• Operational Risks: Continued challenges with state-level Medicaid processes and the need for timely enrollment applications could affect future revenue and participant retention.
• De Novo Losses: Losses from new centers remain a concern, with ongoing investments needed to stabilize these operations.

5. Notable Q&A Insights

• Management acknowledged that while internal processes for Medicaid redeterminations have improved, external state-level processes still pose challenges.
• There was a discussion on the impact of the new Medicare risk adjustment model (v28) and its phased implementation, which could influence future risk scores and rates.
• The company is actively working to reduce voluntary disenrollment through enhanced participant experience initiatives, focusing on the critical first six months of enrollment.
• Management emphasized the importance of understanding participant cohorts and their needs to improve retention and financial contributions over time.

Overall, InnovAge Holding Corp. demonstrated strong financial performance in Q2 2026, with strategic initiatives aimed at enhancing operational efficiency and participant experience, while acknowledging ongoing challenges in enrollment and external regulatory processes.